The Impact of Breast Cancer Screening Among Younger Women in the Barretos Region, Brazil
Carregando...
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
INT INST ANTICANCER RESEARCH
Autores
MATTOS, Jaco Saraiva De Castro
MAUAD, Edmundo Carvalho
SYRJANEN, Kari
HAIKEL, Raphael Luiz
VIEIRA, Rene Aloisio Da Costa
SILVA, Thiago Buosi
Citação
ANTICANCER RESEARCH, v.33, n.6, p.2651-2655, 2013
Resumo
Aim: To verify the impact of breast cancer screening in women aged 40-49 years in one region of Brazil. Patients and Methods: This is a cross-sectional study, targeted to asymptomatic women aged 40-69 years who had breast cancer screening mammography performed between January 2003 and December 2007. Logistic regression was used to estimate the risk of breast cancer by age groups (40-49, 5059, 60-69 years). Results: Of the 27,133 screened women, 51.9% (14,082) were aged between 40-49 years. The odds ratio (OR) of breast cancer among the 45-49 year age cohort was not significantly different from that of 60 to 69-year-old women (OR=0.64; 95% Confidence Interval 0.39 to 1.03). Conclusion: The risk of breast cancer among women aged 45 to 49 years is equivalent to that of women aged 60 to 69 years, indicating that breast cancer screening in this region of Brazil should start at the age of 45 years or immediately thereafter.
Palavras-chave
Breast cancer, screening, age groups, younger women
Referências
- Al Sayed AD, 2010, CLIN ONCOL S, V28
- American College of Radiology (2003), 2003, ACR BREAST IM REP DA
- Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862
- Anderson BO, 2010, CANCER-AM CANCER SOC, V116, P4436, DOI 10.1002/cncr.25361
- Australian Institute of Health and Welfare & National Breast and Ovarian Cancer Centre, 2009, AUSTR I HLTH WELF CA, V50
- Bedwani R, 2001, ANTICANCER RES, V21, P3011
- Bjurstam N, 2003, CANCER, V97, P2387, DOI 10.1002/cncr.11361
- Boder JME, 2010, ONCOL LETT, V2, P323
- Bowen RL, 2008, BRIT J CANCER, V98, P277, DOI 10.1038/sj.bjc.6604174
- Brasil. Ministerio da Saude, 2011, CANC SAO PAUL 1997 2
- Brasil. Ministerio da Saude. Instituto Nacional de Cancer Jose Alencar Gomes da Silva (INCA), 2011, COORD GER AC ESTR CO
- Cheng SH, 2000, BREAST CANCER RES TR, V63, P213, DOI 10.1023/A:1006468514396
- COLLETTE HJA, 1992, J EPIDEMIOL COMMUN H, V46, P382, DOI 10.1136/jech.46.4.382
- Colonna M, 2008, BREAST, V17, P289, DOI 10.1016/j.breast.2007.10.017
- Elgaili Elgaili M, 2010, Int J Womens Health, V2, P77
- El-Habbash MM, 2009, SAUDI MED J, V30, P1060
- El-Zaemey S, 2012, CANCER EPIDEMIOL, V36, P249, DOI 10.1016/j.canep.2012.01.006
- Tessema Ersumo, 2006, East and Central African Journal of Surgery, V11, P81
- Faria EF, 2011, CLIN GENITOURIN CANC, V9, P104, DOI 10.1016/j.clgc.2011.06.004
- Giuliano A, 1998, PREV MED, V27, P135, DOI 10.1006/pmed.1997.0258
- Governo Federal, 2011, COM IPEA 91 DIN DEOG, P18
- Harirchi I, 2010, EUR J CANCER PREV, V19, P126, DOI 10.1097/CEJ.0b013e328333d0b3
- Holleczek B, 2011, CANCER EPIDEMIOL, V35, P399, DOI 10.1016/j.canep.2011.01.008
- Howlader N., 2009, SEER CANC STAT REV 1
- Innes K, 2000, AM J EPIDEMIOL, V152, P1121, DOI 10.1093/aje/152.12.1121
- Jack RH, 2012, INT J CANCER, V130, P1227, DOI 10.1002/ijc.26088
- Jemal Ahmedin, 2011, CA Cancer J Clin, V61, P69, DOI 10.3322/caac.20107
- Kerlikowske K, 1997, JNCI MONOGRAPHS, P79
- KERLIKOWSKE K, 1993, JAMA-J AM MED ASSOC, V270, P2444, DOI 10.1001/jama.270.20.2444
- Kollias J, 1998, EUR J CANCER, V34, P878, DOI 10.1016/S0959-8049(97)00365-1
- Kuo WH, 2009, BRIT J CANCER, V100, P563, DOI 10.1038/sj.bjc.6604898
- LEMARCHAND L, 1988, BRIT J CANCER, V57, P437, DOI 10.1038/bjc.1988.99
- Li J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-364
- Lu WL, 2010, BREAST J, V16, P331, DOI 10.1111/j.1524-4741.2010.00903.x
- Marchi Ailton Augustinho, 2010, Rev Bras Ginecol Obstet, V32, P191, DOI 10.1590/S0100-72032010000400007
- Mauad EC, 2009, RURAL REMOTE HEALTH, V9
- Mauad EC, 2011, J MED SCREEN, V18, P51, DOI 10.1258/jms.2011.010124
- Merlo DF, 2012, BREAST CANCER RES TR, V134, P363, DOI 10.1007/s10549-012-2031-7
- Motawy Mohamed, 2004, J Egypt Natl Canc Inst, V16, P85
- Mousavi SM, 2009, BREAST J, V15, P677, DOI 10.1111/j.1524-4741.2009.00843.x
- Ohene-Yeboah M, 2012, Ghana Med J, V46, P8
- Sanderson M, 1996, EPIDEMIOLOGY, V7, P34, DOI 10.1097/00001648-199601000-00007
- TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H
- Thiebaut ACM, 2007, J NATL CANCER I, V99, P451, DOI 10.1093/jnci/djk094
- Weiss HA, 1997, EPIDEMIOLOGY, V8, P181, DOI 10.1097/00001648-199703000-00010
- Zakharova N, 2011, Ecancermedicalscience, V5, P195, DOI 10.3332/ecancer.2011.195
- Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054